JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community
July 08 2020 - 9:00AM
Business Wire
JDRF, the leading global organization funding type 1 diabetes
(T1D) research, and Tandem Diabetes Care (NASDAQ: TNDM), a medical
device company dedicated to improving the lives of people with
diabetes through relentless innovation and revolutionary customer
experience, announce a new national partnership to help drive
awareness and education on topics related to technology innovation,
diabetes management, and healthcare for people with diabetes.
The partnership will utilize JDRF’s community facing platforms,
including local chapter events, digital channels, and education
programs, to bring to life the benefits of devices such as insulin
pumps, continuous glucose monitors and novel treatment approaches
like hybrid closed loop therapy.
“Together, we will show how innovations in type 1 diabetes
management and care will continue to minimize the intrusions of T1D
on day-to-day life and provide better health outcomes for people
living with the disease,” said Joe Watterson, JDRF Vice President
of Corporate Development.
People living with T1D have a variety of needs that span from
reducing the daily burden of disease management to finding a
trusted technology partner who can deliver solutions that work
reliably, provide clinical benefits, and improve their overall
quality of life. The JDRF and Tandem partnership aims to actively
support the growing needs of the T1D community and help address the
gap in diabetes education on these topics through regional and
local activities, including select Type One Nation Summits and JDRF
One Walk events.
“Education is the foundation for improved quality of life and
clinical outcomes for people with type 1 diabetes, and we are proud
to partner with JDRF in furthering our shared mission to support
the diabetes community,” said Brian Hansen, Executive Vice
President and Chief Commercial Officer at Tandem Diabetes Care.
About JDRF
JDRF’s mission is to accelerate life-changing breakthroughs to
cure, prevent and treat T1D and its complications. To accomplish
this, JDRF has invested more than $2.2 billion in research funding
since our inception. We are an organization built on a grassroots
model of people connecting in their local communities,
collaborating regionally for efficiency and broader fundraising
impact, and uniting on a national stage to pool resources, passion,
and energy. We collaborate with academic institutions,
policymakers, and corporate and industry partners to develop and
deliver a pipeline of innovative therapies to people living with
T1D. Our staff and volunteers throughout the United States and our
six international affiliates are dedicated to advocacy, community
engagement and our vision of a world without T1D. For more
information, please visit jdrf.org or follow us on Twitter:
@JDRF
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical
device company dedicated to improving the lives of people with
diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach
to the design, development and commercialization of products for
people with diabetes who use insulin. Tandem’s flagship product,
the t:slim X2™ insulin pump, is capable of remote software updates
using a personal computer and features integrated continuous
glucose monitoring. Tandem is based in San Diego, California.
Tandem Diabetes Care is a registered trademark and t:slim X2 is
a trademark of Tandem Diabetes Care, Inc.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use
#tslimX2, and $TNDM. Follow Tandem Diabetes Care on Facebook at
www.facebook.com/TandemDiabetes. Follow Tandem Diabetes Care on
LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200708005307/en/
JDRF Contact Information: Ayana Young, 347-496-2494,
ayoung@jdrf.org
Tandem Diabetes Care Contact Information: Media: Steve
Sabicer, 714-907-6264, ssabicer@thesabicergroup.com Investors:
Susan Morrison, 858-366-6900 x7005, IR@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Apr 2023 to Apr 2024